Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Weilun Biopharmaceutical is a Chinese biopharmaceutical company specializing in the research, development, and manufacture of plasma-derived therapeutics. Based in Shantou, the company operates as a subsidiary of China Biologic Products Holdings and maintains a robust portfolio of blood products including human albumin and various specific immunoglobulins. Its facilities are GMP-certified, supporting the production of critical treatments for immunodeficiencies, coagulation disorders, and infectious disease prophylaxis. The company plays a significant role in the regional supply of life-saving blood-based medicines within the Chinese healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Weilun Biopharmaceutical.